CN1054613A - 一种在预防和治疗人体逆转录病毒中作为抗病毒剂和免疫原的非复制性的重组逆转录病毒颗粒 - Google Patents

一种在预防和治疗人体逆转录病毒中作为抗病毒剂和免疫原的非复制性的重组逆转录病毒颗粒 Download PDF

Info

Publication number
CN1054613A
CN1054613A CN 90110329 CN90110329A CN1054613A CN 1054613 A CN1054613 A CN 1054613A CN 90110329 CN90110329 CN 90110329 CN 90110329 A CN90110329 A CN 90110329A CN 1054613 A CN1054613 A CN 1054613A
Authority
CN
China
Prior art keywords
hiv
particle
replicability
gene
reorganization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 90110329
Other languages
English (en)
Chinese (zh)
Inventor
奥马尔·K·哈发
阿伦·W·塞尼尔
布鲁斯·M·特拉维斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncogen LP
Original Assignee
Oncogen LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen LP filed Critical Oncogen LP
Publication of CN1054613A publication Critical patent/CN1054613A/zh
Pending legal-status Critical Current

Links

Images

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CN 90110329 1989-11-20 1990-11-20 一种在预防和治疗人体逆转录病毒中作为抗病毒剂和免疫原的非复制性的重组逆转录病毒颗粒 Pending CN1054613A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US43920589A 1989-11-20 1989-11-20
US439,205 1989-11-20
US61575690A 1990-11-19 1990-11-19
US615,756 1996-03-13

Publications (1)

Publication Number Publication Date
CN1054613A true CN1054613A (zh) 1991-09-18

Family

ID=27031958

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 90110329 Pending CN1054613A (zh) 1989-11-20 1990-11-20 一种在预防和治疗人体逆转录病毒中作为抗病毒剂和免疫原的非复制性的重组逆转录病毒颗粒

Country Status (5)

Country Link
CN (1) CN1054613A (pt)
IE (1) IE904161A1 (pt)
IL (1) IL96404A0 (pt)
MY (1) MY104530A (pt)
PT (1) PT95939A (pt)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104450631A (zh) * 2014-11-11 2015-03-25 中国人民解放军第四军医大学 肠道病毒ev71型vp1基因病毒样颗粒及其制备方法和应用

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6428790B1 (en) 1995-04-27 2002-08-06 The United States Of America As Represented By The Secretary Department Of Health And Human Services Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use
US6780847B2 (en) 1995-04-27 2004-08-24 The United States Of America As Represented By The Department Of Health And Human Services Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins
US6987096B1 (en) 1995-04-27 2006-01-17 The United States Of America As Represented By The Department Of Health And Human Services Antiviral proteins and peptides, DNA coding sequences therefor, and uses thereof
US7048935B2 (en) 1995-04-27 2006-05-23 The United States Of America As Represented By The Department Of Health And Human Services Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use
CA2296067C (en) * 1997-07-09 2008-10-07 The University Of Queensland Nucleic acid sequence and method for selectively expressing a protein in a target cell or tissue
AU2002254382B2 (en) 2001-03-22 2007-02-15 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Glycosylation-resistant and nonglycosylated cyanovirins

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104450631A (zh) * 2014-11-11 2015-03-25 中国人民解放军第四军医大学 肠道病毒ev71型vp1基因病毒样颗粒及其制备方法和应用

Also Published As

Publication number Publication date
PT95939A (pt) 1991-09-13
MY104530A (en) 1994-04-30
IE904161A1 (en) 1991-05-22
IL96404A0 (en) 1991-08-16

Similar Documents

Publication Publication Date Title
CN1020752C (zh) 后天性免疫缺乏综合征(爱滋病)疫苗
CN1229501C (zh) Hiv多包膜蛋白疫苗的重组痘苗载体混合物
Means et al. Ability of the V3 loop of simian immunodeficiency virus to serve as a target for antibody-mediated neutralization: correlation of neutralization sensitivity, growth in macrophages, and decreased dependence on CD4
CN1257976C (zh) 改良疫苗
CN1147586C (zh) Hiv-1 o组(或亚组)逆转录病毒抗原的核苷酸序列
CN1216064A (zh) 合成的hiv基因
CN1171814A (zh) 多核苷酸结核病疫苗
CN1234078A (zh) 治疗病毒感染的组合物及方法
CN1333873A (zh) Hiv－特异的t－细胞诱导
CN1067382A (zh) 人类乳头状瘤病毒肽的表达以及在致免疫组合物中的应用
CN1038306A (zh) 重组反转录病毒
CN1446102A (zh) 模仿天然病毒感染并诱导对病原体的持久免疫力的遗传疫苗
CN1283121A (zh) 用于预防和治疗接种的hiv－1tat或其衍生物
CN1852734A (zh) 共有/祖先免疫原
CN1018845B (zh) 病毒疫苗
CN1840204A (zh) 用于制备免疫治疗性组合物的慢病毒载体
CN1202799A (zh) 使用含有病毒和细胞结合区域的分子增强病毒介导的dna转移的方法
CN1764474A (zh) 免疫原性组合物及方法
CN1688702A (zh) 表达rna病毒抗原表位的重组麻疹病毒在制备疫苗组合物中的用途
JP2000506727A (ja) 組換え生ネコ免疫不全ウイルスおよびプロウイルスｄｎａワクチン
CN1068266A (zh) 人免疫缺陷病毒的疫苗及其治疗方法
CN1227610A (zh) 抗cd4和趋化因子受体结构域复合物的抗体及其抵抗hiv感染的应用
CN1054613A (zh) 一种在预防和治疗人体逆转录病毒中作为抗病毒剂和免疫原的非复制性的重组逆转录病毒颗粒
CN87106696A (zh) 蛋白质及其制备方法，adn的顺序，抗体及其用途，痘病病毒，被转化或感染的细胞用于预防血吸虫病的药剂组合物，以及作为谷胱甘肽-s-转移酶活性的显示剂的用途
CN1714100A (zh) 抗原肽

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication